Literature DB >> 19629665

Fluctuation in ventricular sensing leading to underdetection of ventricular fibrillation in a patient with cardiac sarcoidosis.

Joseph L Schuller1, Christopher M Lowery, Howard D Weinberger, William H Sauer.   

Abstract

In this case report, we describe markedly fluctuating ventricular sensing through an implantable cardioverter defibrillator (ICD) over a period of 29 months in a patient with cardiac sarcoidosis. We conclude that the fluctuations in the measured R wave are the result of waxing and waning inflammation associated with sarcoid activity. The patient had a stable medical course throughout the time period studied, including stable immunosuppression and stable electrolytes. We believe this is an example of an important complication of ICD implants in patients with cardiac sarcoidosis and that frequent sensing evaluations are prudent in these patients.

Entities:  

Mesh:

Year:  2009        PMID: 19629665     DOI: 10.1007/s10840-009-9424-5

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  5 in total

1.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2008-05-15       Impact factor: 29.690

Review 2.  Current concepts of the pathogenesis of sarcoidosis.

Authors:  P D Thomas; G W Hunninghake
Journal:  Am Rev Respir Dis       Date:  1987-03

Review 3.  Sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower; Roland M du Bois
Journal:  Lancet       Date:  2003-03-29       Impact factor: 79.321

Review 4.  Pathogenesis of the granulomatous lung diseases.

Authors:  G W Hunninghake; K C Garrett; H B Richerson; J C Fantone; P A Ward; S I Rennard; P B Bitterman; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1984-09

5.  Cardiac sarcoidosis: a retrospective study of 41 cases.

Authors:  Catherine Chapelon-Abric; Dominique de Zuttere; Pierre Duhaut; Pierre Veyssier; Bertrand Wechsler; Du Le Thi Huong; Christian de Gennes; Thomas Papo; Olivier Blétry; Pierre Godeau; Jean-Charles Piette
Journal:  Medicine (Baltimore)       Date:  2004-11       Impact factor: 1.889

  5 in total
  1 in total

1.  Heart Failure, Atrioventricular Block, and Ventricular Tachycardia in Sarcoidosis.

Authors:  David G Rosenthal; Christina D Fang; Christopher A Groh; Gregory Nah; Eric Vittinghoff; Thomas A Dewland; Vasanth Vedantham; Gregory M Marcus
Journal:  J Am Heart Assoc       Date:  2021-02-18       Impact factor: 5.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.